Ingevity Analyst Ratings
Ingevity Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/07/2023 | 3.16% | BMO Capital | $71 → $60 | Downgrades | Outperform → Market Perform |
07/27/2023 | — | Loop Capital | Upgrades | Hold → Buy | |
05/23/2023 | -5.43% | Wells Fargo | $66 → $55 | Maintains | Equal-Weight |
05/09/2023 | 37.55% | BMO Capital | $100 → $80 | Maintains | Outperform |
05/05/2023 | 13.48% | Wells Fargo | $80 → $66 | Maintains | Equal-Weight |
05/05/2023 | 10.04% | Loop Capital | $92 → $64 | Downgrades | Buy → Hold |
04/17/2023 | 37.55% | Wells Fargo | $85 → $80 | Maintains | Equal-Weight |
03/24/2023 | 58.18% | Loop Capital | $100 → $92 | Maintains | Buy |
03/01/2023 | 46.15% | Wells Fargo | $76 → $85 | Maintains | Equal-Weight |
02/02/2023 | 71.94% | Loop Capital | $81 → $100 | Upgrades | Hold → Buy |
01/09/2023 | 30.67% | Wells Fargo | $73 → $76 | Maintains | Equal-Weight |
11/04/2022 | 25.52% | Wells Fargo | $67 → $73 | Maintains | Equal-Weight |
10/18/2022 | 15.2% | Wells Fargo | $74 → $67 | Maintains | Equal-Weight |
10/11/2022 | 49.59% | BMO Capital | $89 → $87 | Maintains | Outperform |
05/09/2022 | 27.24% | Wells Fargo | $70 → $74 | Maintains | Equal-Weight |
10/29/2021 | 44.43% | Wells Fargo | $82 → $84 | Maintains | Equal-Weight |
07/29/2021 | 63.34% | Oppenheimer | $85 → $95 | Maintains | Outperform |
05/04/2021 | 89.13% | BMO Capital | $100 → $110 | Maintains | Outperform |
08/06/2020 | 44.43% | BMO Capital | $79 → $84 | Maintains | Outperform |
07/31/2020 | 13.48% | Stifel | $55 → $66 | Upgrades | Hold → Buy |
05/01/2020 | -5.43% | Wells Fargo | $43 → $55 | Maintains | Equal-Weight |
04/30/2020 | 11.76% | Oppenheimer | $80 → $65 | Maintains | Outperform |
04/03/2020 | -26.07% | Wells Fargo | → $43 | Downgrades | Overweight → Equal-Weight |
03/24/2020 | -27.79% | Stifel | $67 → $42 | Maintains | Hold |
02/21/2020 | 15.2% | Stifel | $76 → $67 | Maintains | Hold |
01/24/2020 | — | Loop Capital | Upgrades | Hold → Buy | |
12/06/2019 | 65.06% | Loop Capital | → $96 | Downgrades | Buy → Hold |
10/16/2019 | 71.94% | Wells Fargo | → $100 | Initiates Coverage On | → Outperform |
09/27/2019 | 118.36% | BMO Capital | $131 → $127 | Maintains | Outperform |
09/25/2019 | 70.22% | Stifel | $109 → $99 | Maintains | Hold |
09/05/2019 | — | Loop Capital | Upgrades | Hold → Buy | |
07/19/2019 | 83.98% | Jefferies | $129 → $107 | Downgrades | Buy → Hold |
07/18/2019 | — | BMO Capital | Initiates Coverage On | → Outperform | |
05/28/2019 | — | Berenberg | Upgrades | Hold → Buy | |
05/28/2019 | 89.13% | Berenberg | $120 → $110 | Upgrades | Hold → Buy |
04/08/2019 | 123.52% | Oppenheimer | $110 → $130 | Maintains | Outperform |
12/11/2018 | 44.43% | Stifel | → $84 | Initiates Coverage On | → Hold |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
08/07/2023 | 3.16% | 蒙特利尔银行资本 | $71→$60 | 评级下调 | 跑赢→市场表现 |
07/27/2023 | - | 环路资本 | 升级 | 持有→购买 | |
2023年05月23日 | -5.43% | 富国银行 | $66→$55 | 维护 | 等重 |
05/09/2023 | 37.55% | 蒙特利尔银行资本 | $100→$80 | 维护 | 跑赢大盘 |
05/05/2023 | 13.48% | 富国银行 | $80→$66 | 维护 | 等重 |
05/05/2023 | 10.04% | 环路资本 | $92→$64 | 评级下调 | 购买→Hold |
04/17/2023 | 37.55% | 富国银行 | $85→$80 | 维护 | 等重 |
03/24/2023 | 58.18% | 环路资本 | $100→$92 | 维护 | 买 |
03/01/2023 | 46.15% | 富国银行 | $76→$85 | 维护 | 等重 |
02/02/2023 | 71.94% | 环路资本 | $81→$100 | 升级 | 持有→购买 |
01/09/2023 | 30.67% | 富国银行 | $73→$76 | 维护 | 等重 |
11/04/2022 | 25.52% | 富国银行 | $67→$73 | 维护 | 等重 |
10/18/2022 | 15.2% | 富国银行 | $74→$67 | 维护 | 等重 |
2022年10月11日 | 49.59% | 蒙特利尔银行资本 | $89→$87 | 维护 | 跑赢大盘 |
05/09/2022 | 27.24% | 富国银行 | $70→$74 | 维护 | 等重 |
10/29/2021 | 44.43% | 富国银行 | $82→$84 | 维护 | 等重 |
07/29/2021 | 63.34% | 奥本海默 | $85→$95 | 维护 | 跑赢大盘 |
05/04/2021 | 89.13% | 蒙特利尔银行资本 | $100→$110 | 维护 | 跑赢大盘 |
08/06/2020 | 44.43% | 蒙特利尔银行资本 | $79→$84 | 维护 | 跑赢大盘 |
07/31/2020 | 13.48% | Stifel | $55→$66 | 升级 | 持有→购买 |
05/01/2020 | -5.43% | 富国银行 | $43→$55 | 维护 | 等重 |
04/30/2020 | 11.76% | 奥本海默 | $80→$65 | 维护 | 跑赢大盘 |
04/03/2020 | -26.07% | 富国银行 | →$43 | 评级下调 | 超重→等重 |
03/24/2020 | -27.79% | Stifel | $67→$42 | 维护 | 保持 |
02/21/2020 | 15.2% | Stifel | $76→$67 | 维护 | 保持 |
1/24/2020 | - | 环路资本 | 升级 | 持有→购买 | |
2019年6月12日 | 65.06% | 环路资本 | →$96 | 评级下调 | 购买→Hold |
2019年10月16日 | 71.94% | 富国银行 | →$100 | 开始承保 | →跑赢大盘 |
2019年09月27日 | 118.36% | 蒙特利尔银行资本 | $131→$127 | 维护 | 跑赢大盘 |
2019年09月25日 | 70.22% | Stifel | $109→$99 | 维护 | 保持 |
2019年05月09日 | - | 环路资本 | 升级 | 持有→购买 | |
2019年07月19日 | 83.98% | 杰富瑞 | $129→$107 | 评级下调 | 购买→Hold |
2019年07月18日 | - | 蒙特利尔银行资本 | 开始承保 | →跑赢大盘 | |
2019年05月28日 | - | 贝伦伯格 | 升级 | 持有→购买 | |
2019年05月28日 | 89.13% | 贝伦伯格 | $120→$110 | 升级 | 持有→购买 |
2019年08月04日 | 123.52% | 奥本海默 | $110→$130 | 维护 | 跑赢大盘 |
2018年12月11日 | 44.43% | Stifel | →$84 | 开始承保 | →保留 |
What is the target price for Ingevity (NGVT)?
英杰华(Ingevity)的目标价是多少?
The latest price target for Ingevity (NYSE: NGVT) was reported by BMO Capital on August 7, 2023. The analyst firm set a price target for $60.00 expecting NGVT to rise to within 12 months (a possible 3.16% upside). 14 analyst firms have reported ratings in the last year.
BMO Capital于2023年8月7日报道了Ingevity(纽约证券交易所代码:NGVT)的最新目标价。这家分析公司将目标价定为60.00美元,预计NGVT将在12个月内升至(可能上涨3.16%)。过去一年,有14家分析公司公布了评级。
What is the most recent analyst rating for Ingevity (NGVT)?
Ingevity(NGVT)的最新分析师评级是多少?
The latest analyst rating for Ingevity (NYSE: NGVT) was provided by BMO Capital, and Ingevity downgraded their market perform rating.
BMO Capital提供了对Ingevity(纽约证券交易所代码:NGVT)的最新分析师评级,Ingevity下调了他们的市场表现评级。
When is the next analyst rating going to be posted or updated for Ingevity (NGVT)?
Ingevity(NGVT)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ingevity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ingevity was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Ingevity的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Ingevity的上一次评级是在2023年8月7日提交的,所以你应该预计下一次评级将在2024年8月7日左右提供。
Is the Analyst Rating Ingevity (NGVT) correct?
分析师评级Ingevity(NGVT)正确吗?
While ratings are subjective and will change, the latest Ingevity (NGVT) rating was a downgraded with a price target of $71.00 to $60.00. The current price Ingevity (NGVT) is trading at is $58.16, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的Ingevity(NGVT)评级被下调,目标价为71.00美元至60.00美元。英杰华(Ingevity)目前的股价为58.16美元,超出了分析师的预测区间。